Holen Sie sich die Stockscreener-App
49.65
1.17%
0.3413
Schlusskurs vom Vortag:
$49.31
Offen:
$49.22
24-Stunden-Volumen:
2,612
Relative Volume:
0.04
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.40%
1M Leistung:
+4.06%
6M Leistung:
+21.06%
1J Leistung:
+8.45%
1-Tages-Spanne:
$49.22
$49.89
1-Wochen-Bereich:
$48.29
$49.89
52-Wochen-Spanne:
$35.22
$49.89
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
49.68 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.67 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
682.95 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
631.71 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
P Pharmaceuticals ETF stock responds to job market shiftsWeekly Trade Analysis & Fast Moving Stock Trade Plans - newser.com
Aug Analyst Calls: P Pharmaceuticals ETF stock enhance shareholder valueMarket Movers & Daily Chart Pattern Signals - nchmf.gov.vn
P Pharmaceuticals ETF stock enhance shareholder value2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
P Pharmaceuticals ETF stock prepared for digital transition2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
P Pharmaceuticals ETF stock overpriced at current multiples2025 Retail Activity & Daily Chart Pattern Signal Reports - Trung tâm Dự báo KTTV quốc gia
P Pharmaceuticals ETF stock return to pre crash levelsProduct Launch & Daily Risk Controlled Trade Plans - Trung tâm Dự báo KTTV quốc gia
SPDR Series TrustSPDR S&P Pharmaceuticals ETF (SSGE.HM) latest stock news and headlines - Yahoo
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks - MSN
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
P Pharmaceuticals ETF stock beat international competitionJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
SPDR Pharmaceuticals ETF Index (^KZP) options chain - Yahoo
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - inkl
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - TradingView
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):